Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties

E-ISSN： 1875-5305|20|4|412-423

ISSN： 0929-8665

Source： Protein and Peptide Letters, Vol.20, Iss.4, 2013-04, pp. : 412-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis of novel peptides through Ugi-ligation and their anti-cancer activities

By Tahoori Fatemeh Sheikhnejad Reza Balalaie Saeed Sadjadi Mahnaz

Amino Acids, Vol. 45, Iss. 4, 2013-10 ,pp. : 975-981

Springer Publishing Company

Access to resources Recommend Favorite

Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders

By Tilg Herbert Kaser Arthur

Expert Opinion on Biological Therapy, Vol. 4, Iss. 4, 2004-04 ,pp. : 469-481

Informa Healthcare

Access to resources Recommend Favorite

Mutational and Structural Analysis of the Binding Interface between Type I Interferons and their Receptor Ifnar2

By Piehler J. Schreiber G.

Journal of Molecular Biology, Vol. 294, Iss. 1, 1999-11 ,pp. : 223-237

Academic Press

Access to resources Recommend Favorite

Cathelicidins: Peptides with Antimicrobial, Immunomodulatory, Anti- Inflammatory, Angiogenic, Anticancer and Procancer Activities

Current Protein and Peptide Science, Vol. 14, Iss. 6, 2013-09 ,pp. : 504-514

Bentham Science Publishers

Access to resources Recommend Favorite

Platinum(II) intercalators as potential anti-cancer agents

By Fisher D.M. Fenton R.R. Aldrich-Wright J.R.

Journal of Inorganic Biochemistry, Vol. 96, Iss. 1, 2003-07 ,pp. : 131-131

Elsevier

Access to resources Recommend Favorite